Sangamo Therapeutics
SGMO
#10562
Rank
C$42.58 M
Marketcap
C$0.10
Share price
0.00%
Change (1 day)
-86.14%
Change (1 year)

EPS for Sangamo Therapeutics (SGMO)

EPS in 2026 (TTM): C-$0.52

According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is C-$0.53. In 2025 the company made an earnings per share (EPS) of C-$0.61 an increase over its 2024 EPS that were of C-$0.71.

EPS history for Sangamo Therapeutics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$0.52-14.29%
2025C-$0.61-13.73%
2024C-$0.71
2022C-$1.740.81%
2021C-$1.7233.33%
2020C-$1.296.9%
2019C-$1.2122.54%
2018C-$0.991.43%
2017C-$0.97-31.37%
2016C-$1.4275.86%
2015C-$0.8148.72%
2014C-$0.54-17.02%
2013C-$0.659.3%
2012C-$0.60-39.44%
2011C-$0.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.13-2,398.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$20.11-3,910.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$12.99-2,560.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
C-$5.54 950.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$10.31-2,052.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$4.97-1,040.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$5.26-1,097.37%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$1.94-468.42%๐Ÿ‡บ๐Ÿ‡ธ USA